Default company panoramic image
Logo

Acera Surgical, Inc.

Acera Surgical is a medical device company producing nanofabricated surgical materials offering improved clinical outcomes and significant cost savings.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded December 2012
  • Employees 5
  • Website acerasurgical.com

Company Summary

Acera Surgical, Inc. is a medical device company producing a first-in-class line of implantable nanofabricated surgical materials and related tools/accessories offering superior handling, greater ease of use, increased reliability, and improved clinical outcomes for surgeons, patients, and payers. Acera's primary offering is the CerafixTM Dural Substitute. Acera is projected to submit 510k documentation in Q3 2014 with US market entry in Q4 2014.

Team

  • Default avatar
    Matthew R MacEwan
    Founder / President

    Matthew is an MD/PhD Candidate at Washington University School of Medicine in St. Louis, MO. Matthew graduated Summa Cum Laude with a degree in Biomedical Engineering from Case Western Reserve University, and has received multiple awards for his entrepreneurial work in the lifescience community, including the 2011 Olin Cup Award, and Grand Prize at the 2011 LES Global Business Plan Competition.

  • Default avatar
    Agnes Rey-Giraud
    CEO

    Agnès recently retired from Express Scripts, Inc., where she served as President of International Operations. Agnès joined Express Scripts in 1999, and quickly became a driving force behind the transformation of the company from a $4 billion to a $44 billion enterprise. Agnès earned a Master of Science in Mechanical Engineering from Ecole Nationale d'Ingénieurs de Saint Etienne, as well as an MBA from the University of Chicago.

  • Default avatar
    Julie Cochran
    VP, Business Development

    Julie has significant experience working in both pharmaceutical, medical device and the biotechnology corporations such as Express Scripts and McKinsey and Company, Inc. Julie graduated summa cum laude with a Bachelors of Science in both Biomedical Engineering and Electrical Engineering from Duke University and earned an MBA from the Stanford Graduate School of Business.

  • Default avatar
    Rhonda Soest
    VP, Sales & Marketing

    Rhonda is a clinician and a Marketing and Commercialization Executive who has successful leadership experience. Rhonda delivered net sales and GAAP above targets in highly competitive and price sensitive markets for OrthoBiotech, Inc., Johnson & Johnson, Inc., and Covidien, Inc.

  • Default avatar
    Tamas Kovacs
    Project Manager

    Tamas spent the last 2 years in China as a project manager for a Fortune 100 company within the healthcare services industry. After earning a bachelor’s degree in Operations Research and Industrial Engineering, Tamás went on to receive a M.Eng in Engineering Management, both degrees from Cornell University.

Advisors

  • Default avatar
    Polsinelli Shughart, Global Patent Group, KMOB
    Legal Support
    Unconfirmed
    Default avatar
    Rubin Brown
    Accounting
    Unconfirmed

Previous Investors

  • Default avatar
    Washington University in St. Louis
    Unconfirmed
    Default avatar
    Private Investors
    Unconfirmed